BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Wang Y, Liu Z, Yao B, Dou C, Xu M, Li Q, Jia Y, Wu S, Tu K, Liu Q. Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. FEBS Open Bio 2016;6:1227-37. [PMID: 28255535 DOI: 10.1002/2211-5463.12139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Koral K, Haynes M, Bowen WC, Orr A, Mars W, Michalopoulos GK. Lymphocyte-Specific Protein-1 Controls Sorafenib Sensitivity and Hepatocellular Proliferation through Extracellular Signal-Regulated Kinase 1/2 Activation. Am J Pathol 2018;188:2074-86. [PMID: 30126548 DOI: 10.1016/j.ajpath.2018.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Lubecka K, Flower K, Beetch M, Qiu J, Kurzava L, Buvala H, Ruhayel A, Gawrieh S, Liangpunsakul S, Gonzalez T, McCabe G, Chalasani N, Flanagan JM, Stefanska B. Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development. Epigenetics 2018;13:605-26. [PMID: 29927686 DOI: 10.1080/15592294.2018.1481706] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu Y, Zhang M. miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1. Cancer Biother Radiopharm 2019;34:398-404. [PMID: 30939040 DOI: 10.1089/cbr.2018.2749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
4 Mishra R, Haldar S, Suchanti S, Bhowmick NA. Epigenetic changes in fibroblasts drive cancer metabolism and differentiation. Endocr Relat Cancer 2019;26:R673-88. [PMID: 31627186 DOI: 10.1530/ERC-19-0347] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
5 Cong P, Hou HY, Wei W, Zhou Y, Yu XM. MiR-920 and LSP1 co-regulate the growth and migration of glioblastoma cells by modulation of JAK2/STAT5 pathway. J Bioenerg Biomembr 2020;52:311-20. [PMID: 32770294 DOI: 10.1007/s10863-020-09848-2] [Reference Citation Analysis]
6 Zhao X, Li Y, Wu H. A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes. Int J Mol Med 2018;42:1495-507. [PMID: 29956722 DOI: 10.3892/ijmm.2018.3739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
7 Al-Eitan LN, M Rababa'h D, Aman HA. The Associations of Common Genetic Susceptibility Variants with Breast Cancer in Jordanian Arabs: A Case-Control Study. Asian Pac J Cancer Prev 2020;21:3045-54. [PMID: 33112566 DOI: 10.31557/APJCP.2020.21.10.3045] [Reference Citation Analysis]
8 Nguyen Thi Ngoc Thanh, Tram PB, Tuyet NHH, Uyen NHP, Tien LTM, Anh DN, Van LTT, Luan HH, Hue NT. Association of Polymorphisms in Genes Involved in DNA Repair and Cell Cycle Arrest with Breast Cancer in a Vietnamese Case-Control Cohort. Cytol Genet 2021;55:388-95. [DOI: 10.3103/s0095452721040101] [Reference Citation Analysis]
9 Schinke CD, Bird JT, Qu P, Yaccoby S, Lyzogubov VV, Shelton R, Ling W, Boyle EM, Deshpande S, Byrum SD, Washam C, Mackintosh S, Stephens O, Thanendrarajan S, Zangari M, Shaughnessy J Jr, Zhan F, Barlogie B, van Rhee F, Walker BA. PHF19 inhibition as a therapeutic target in multiple myeloma. Curr Res Transl Med 2021;69:103290. [PMID: 33894670 DOI: 10.1016/j.retram.2021.103290] [Reference Citation Analysis]
10 McGrath J, Panzica L, Ransom R, Withers HG, Gelman IH. Identification of Genes Regulating Breast Cancer Dormancy in 3D Bone Endosteal Niche Cultures. Mol Cancer Res 2019;17:860-9. [PMID: 30651373 DOI: 10.1158/1541-7786.MCR-18-0956] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]